Jaleva is engaged in the research and development of its patented resin delivery vehicle for active ingredients that treat surgical preparation, post-surgery applications, waterless surgical hand scrub, surgical drapes, psoriasis, sustained delivery of bacitracin for wound healing, and 'patchless' transdermal delivery of nicotine as an aid to smoking cessation.
Many topical dermatologic treatments use delivery vehicles such as powders, sprays, solutions, lotions, lacquers and creams to deliver an active ingredient to the skin. However, these delivery vehicles often lack effectiveness as the application of the product comes off easily once applied to an affected area of the skin, resulting in poor delivery of the active medication.
The Company's patented resin technology safely keeps 100% of an active ingredient in place on the skin, providing a controlled rate of release of the active ingredient over a sustained period of time. As a result, Jaleva has consistently demonstrated that its formulations out-perform market leaders in product categories such as pre-operative surgical preparations, post-operative wound healing and toenail fungus.
